Insight Molecular Diagnostics Inc. (IMDX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-07

Insight Molecular Diagnostics Inc. (IMDX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 3 Form 8-K material event filings were reported by IMDX in the last 90 days. InsiderAlpha tracks every IMDX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Insight Molecular Diagnostics Inc. (IMDX)

SEC CIK	0001642380

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-07-07

Recent IMDX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-01	Arno Andrew	Director	F — Tax withholding / forfeiture	12.1K	$5.69	$69K	SEC
2026-07-01	Last Andrew J.	Director	F — Tax withholding / forfeiture	7.7K	$5.69	$44K	SEC
2026-07-01	SILVERMAN LOU	Director	F — Tax withholding / forfeiture	7.7K	$5.69	$44K	SEC
2026-06-11	Last Andrew J.	Director	A — Grant or award	26.9K	$0.00	—	SEC
2026-06-11	SILVERMAN LOU	Director	A — Grant or award	26.9K	$0.00	—	SEC
2026-06-11	Arno Andrew	Director	A — Grant or award	32.3K	$0.00	—	SEC
2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	250.9K	$3.64	$913K	SEC
2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	0	$0.00	—	SEC
2026-04-24	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	0	$0.00	—	SEC
2026-04-24	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	38.9K	$3.53	$137K	SEC
2026-04-23	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	0	$0.00	—	SEC
2026-04-23	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	280.4K	$3.50	$982K	SEC
2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	40.7K	$3.88	$158K	SEC
2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	0	$0.00	—	SEC
2026-04-17	BROADWOOD PARTNERS, L.P.	10% Owner	P — Open-market purchase	40.1K	$3.57	$143K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Insight Molecular Diagnostics Inc. (IMDX). Updated in real time as new filings are submitted to the SEC.

Most-Active IMDX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
BROADWOOD PARTNERS, L.P.	12	$2.69M
SILVERMAN LOU	2	$44K
Arno Andrew	2	$69K
Last Andrew J.	2	$44K

Recent IMDX Form 8-K Material Events

2026-06-17 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-13 — Item 2.02, 9.01 [SEC]
2026-05-13 — Item 8.01 [SEC]
2026-03-26 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Insight Molecular Diagnostics Inc. announced financial results for the three and twelve months ended December 31, 2025 via press release on March 26, 2026. The filing provides standard quarterly and annual financial results without explicit beat/miss or guidance language.
2026-02-26 — Item 1.01, 9.01 · Contract · neutral [SEC]
Insight Molecular Diagnostics entered into a Specimen Collection Agreement with Quest Diagnostics on February 20, 2026, whereby Quest will provide collection services for the company's GraftAssureCore™ blood test (measuring donor-derived cell-free DNA). The agreement includes ser

Recent Insider Filings

2026-07-07 — SILVERMAN LOU (Director)
2026-07-07 — Last Andrew J. (Director)
2026-07-07 — Arno Andrew (Director)
2026-06-15 — SILVERMAN LOU (Director)
2026-06-15 — Last Andrew J. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IMDX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

IMDX Insider Trading — FAQ

What is the latest insider trade for IMDX?: Insight Molecular Diagnostics Inc. (IMDX) had 8 insider filings in the last 90 days, with the most recent on 2026-07-07. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying IMDX stock?: 0 insider purchases of IMDX were filed in the last 90 days.
How many insiders are selling IMDX stock?: 0 insider sales of IMDX were filed in the last 90 days.
Where can I see IMDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every IMDX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live IMDX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.